Oral environment and taste function of Japanese HIV-infected patients treated with antiretroviral therapy.
Tomoaki ShintaniT FujiiN YamasakiM KitagawaT IwataS SaitoM OkadaI OgawaH UneiK HamamotoM NakaokaH KuriharaH ShibaPublished in: AIDS care (2019)
The aim of the study was to evaluate the oral environment and the taste function of Japanese HIV-infected patients treated with antiretroviral therapy. Their median age of 73 patients taking anti-HIV drugs was 46 years. The median period of taking anti-HIV drugs was 30 months. The oral condition was evaluated by measurement of oral moisture, amount of saliva secretion, the number of oral bacteria, presence of oral candida, a taste test, and the number of missing teeth. The levels of oral moisture and secreted saliva were significantly lower in the HIV-infected group than in the healthy volunteer (control) group. The HIV-infected group showed a more robust decrease in taste sensation than the control group. The number of missing teeth was significantly higher in the HIV-infected group than in the control group. Furthermore, all of the evaluated oral conditions were worse in the HIV-infected patients whose CD4+ T lymphocyte counts were less than 500/mm3 than in the control group. It became clear that the patients taking anti-HIV drugs, especially the CD4+ count < 500/mm3 group, had a deteriorated oral environment and dysgeusia, suggesting that the management of oral hygiene is necessary to maintain oral health, which leads to systemic health.
Keyphrases
- hiv infected
- antiretroviral therapy
- hiv infected patients
- human immunodeficiency virus
- hiv positive
- hiv aids
- end stage renal disease
- healthcare
- public health
- hepatitis c virus
- chronic kidney disease
- pseudomonas aeruginosa
- oral health
- escherichia coli
- ejection fraction
- peritoneal dialysis
- men who have sex with men
- cystic fibrosis
- biofilm formation
- staphylococcus aureus
- hiv testing